FormWeb • memantine

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search by class Show Therapeutic Classes

Add Formweb to your mobile device

Android iOS

Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

memantine

memantine

Formulary Miscellaneous Program Formulary

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Namenda XR	CAPSULE, EXTENDED RELEASE, ORAL	7 mg, 14 mg, 21 mg, 28 mg
Namenda	TABLET, ORAL	5 mg, 10 mg

VIEW MORE Central Nervous System Agents, Miscellaneous

Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

memantine (Namenda XR)

7 mg extended release capsule oral Daily
14 mg extended release capsule oral Daily
21 mg extended release capsule oral Daily
28 mg extended release capsule oral Daily

memantine (Namenda)

5 mg tablet oral Daily
10 mg tablet oral Daily
THREE 5 mg tablets oral Daily (Total: 15 mg)
20 mg tablet oral Daily OR 10 mg tablet oral BID

Reviewed: August 28, 2013 (NAMENDA XR)

Last updated: Dec. 26, 2017

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.